Bigora Sian bought PCSA

July 24, 2025 · Form 4 insider transaction

Bigora Sian bought 1,659,185 shares of Processa Pharmaceuticals, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.

Direction
Acquired (buy-side)
Shares
1,659,185
Price
$0.00
Total value
N/A
RoleOfficer
SecurityRestricted Stock Units
Transaction codeA: Grant or award
Transaction dateJuly 24, 2025
Filing dateJuly 28, 2025
Shares owned after1,672,087
OwnershipDirect
10b5-1 planNo
AmendedNo

Footnotes

Restricted stock granted under the Processa Pharmaceuticals, Inc. 2019 Omnibus Incentive Plan ("Omnibus Plan"), of which 1,638,778 shares are subject to stockholder approval of the revised Omnibus Plan.; Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock, following its vesting on of one-third on January 1, 2026, and one-thirty-sixth each month thereafter until fully vested on January 1, 2028.

View the original Form 4 on SEC EDGAR